non-Hodgkin's lymphoma

Leah SherwoodAggressive B-Cell Lymphoma | December 22, 2022
The EC granted marketing authorization to axicabtagene ciloleucel for adult patients with DLBCL and HGBL.
Read More
Advertisement
Advertisement
Advertisement
Advertisement
Editorial Board